Movers and Shakers throughout January 2018. Check back weekly for updates!
- J A Kemp Opens Office in Paris
On 1 February 2018, J A Kemp, a leading firm of European and UK Patent and Trademark Attorneys, will open an office in Paris. This will be J A Kemp’s second office in continental Europe. The firm has had an office in Munich since the European Patent Office (EPO) was founded in the 1970s. The opening of the Paris office represents the further expansion of the firm, which has grown 30% in headcount over the past five years and opened an additional UK office in Cambridge two years ago.
Graham Lewis and Jimmy Nicholls, French-speaking patent attorney partners who have both spent their entire careers at J A Kemp, will relocate to Paris to lead the office from day one. James Fish, the partner who heads up the firm’s Trade Marks and Designs Group, will lead the firm’s Paris-based trade marks operation. Other partners who will be closely involved with the Paris office from day one include Dominic Forsythe, a French-speaking patent attorney partner who has also been at J A Kemp throughout his career. Dominic has close family ties in the Paris region and plans to relocate to be based in the Paris office later in 2018.
J A Kemp’s Paris office will offer the full range of patent, trademark and design services, including drafting, prosecution, oppositions, appeals, advice on IP strategy and portfolio management, litigation and dispute resolution. Paris is the proposed home of one of the central divisions of the Unified Patent Court.
J A Kemp has provided patent, trademark and design services to clients based in many different European countries for decades. The firm already has major clients in France. The office in Paris will enhance the firm’s ability to serve not only the needs of clients in France and other European countries but also those of our large and diverse client base in the USA, Japan and throughout the world.
2. Haseltine Lake to host IP workshop at Biotech & Money World Congress 5-6 February 2018, London
Major European patent and trademark attorney firm, Haseltine Lake, unveils its top biotech expert, Isobel Finnie, Partner and UK and European Patent Attorney, who will host a specialist roundtable at the fourth annual Biotech & Money World Congress on 5th – 6th February 2018. Entitled ‘IP Strategies for Success’, the roundtable will be held at the conference in London, from 4 pm.
The interactive roundtable is aimed at professionals within the biotech sector. Since it will focus on raising awareness of the risks and opportunities presented by managing an intellectual property portfolio and understanding the surrounding IP landscape, this roundtable’s topics are essential information for biotech and life sciences companies, and for those who advise or invest in them.
Isobel Finnie has over 18 years’ experience in supporting biotech and life sciences businesses with IP challenges. She has professional expertise in the fields of cancer therapeutics and cancer pro-drugs, dermatology, biomarkers and diagnostics, vaccines, diabetes therapeutics, antibodies, stem cell technologies, DNA sequencing technologies and medical devices. In addition, Isobel handles technologies relating to foodstuffs, cosmetics, household chemicals, biofuels and agricultural chemicals. David Hammond, Partner and UK and European Patent Attorney at Haseltine Lake, will also be attending and can answer any queries across the two-day event.
The Biotech & Money World Congress is a high-calibre, senior executive, conference providing essential education, strategies, solutions and contacts for life science decision makers addressing effective funding, investment, business planning and partnering within their businesses. The 2017 conference officially attracted the largest gathering of active life science investors, making it the go-to event for executives looking to engage in investment and partnering discussions.
3. Clarivate Analytics Completes Executive Leadership Team with Appointment of New President for Life Sciences Division
Clarivate Analytics, the global leader in providing trusted insights and analytics to accelerate the pace of innovation and commercialize ideas, has announced the appointment of Mukhtar Ahmed to the position of President – Life Sciences. His arrival marks a full complement of executive level appointments for Clarivate Analytics since its formation in October 2016. Following significant hiring activity, Mukhtar Ahmed joins a host of new C-suite appointments of global leaders with domain expertise for each business unit and supporting executive functions.
Ahmed brings a wealth of leadership experience to the organization, having worked across biopharmaceutical, technology and life sciences industries. In this role, he will be responsible for the strategic leadership of the division. He will be based in London and will report to Clarivate Analytics CEO Jay Nadler in Philadelphia.
He joins Clarivate Analytics from Bioclinica, where he held the position of president of eHealth Solutions for more than two and a half years. In a career spanning 25 years within the healthcare industry, Ahmed has held senior executive posts at Oracle Corporation, Parexel and Kendle International, and board-level positions with the National Health Service (NHS) in the UK. Ahmed has also served as an industry advisor to a number of medical device, clinical laboratory, mobile health start-up and private equity companies. He is a member of the Royal Society of Medicine and chairs the Digital Health Committee for Life Sciences PA.
Mukhtar Ahmed, President – Life Sciences stated, “I am very proud to be joining Clarivate Analytics as the new president of the Life Sciences division at this pivotal time in its growth. Innovation within the life sciences industry continues at an exciting pace and we need to be at the forefront embracing the opportunity to combine industry intelligence, transformative analytics and data to drive smarter approaches to the issues facing our customers. We have an unrivalled portfolio of assets, industry leading content and expertise across the biopharma innovation lifecycle. I look forward to working with the management team to guide the business forward in 2018, shaping the trends that are changing our industry.”
The Life Sciences division of Clarivate includes the flagship brand, Cortellis – the world’s most comprehensive suite of solutions for life science professionals, providing unmatched content, intelligent search, state of the art analytics and powerful visualization tools. Bringing together data with analytics across the innovation lifecycle, the breadth of content delivered by Clarivate via Cortellis is unrivalled, bringing together a huge range of data across the drug and device innovation lifecycle, to provide new insights to improve success rates and shorten time to market.
Clarivate Analytics is a newly independent, global company with 4000+ employees in more than 40 countries. It was formed from the sale of the IP & Science business of Thomson Reuters to Onex Corporation and Baring Private Equity Asia in October 2016.
Jay Nadler, CEO of Clarivate Analytics said, “As we forge into the New Year and build on the momentum created by our growth, we are delighted to welcome Mukhtar to Clarivate Analytics. His appointment completes our executive leadership team and our new investment in the company will allow us to enhance the content, analytics, products and technology that we provide to our thousands of customers around the globe. Mukhtar’s significant expertise across industries, particularly life sciences, as well as proven leadership experience, make him the ideal candidate to lead our Life Sciences team into the future and will enable the division to accelerate its strategic objectives and support the wider business.”
4. MORRISON & FOERSTER ELECTS 10 PARTNERS
– Morrison & Foerster, a leading global law firm, is pleased to announce the election of 10 lawyers to the firm’s partnership, effective January 1, 2018. The class of 2018 includes six women and four men across multiple practice groups and nine different offices in the U.S., Europe, and Asia.
“I’m delighted to welcome this highly impressive and diverse group of attorneys to the partnership at Morrison & Foerster,” Larren Nashelsky, chair of Morrison & Foerster, said. “Our new partners have demonstrated a strong commitment to exceptional client service and legal excellence. I’m confident that each of these lawyers will contribute to the firm, its clients and the profession for many years to come.”
We’ve picked out the IP focused lawyers that have been elected as partners and highlighted them, below:
• Ryan Malloy, a member of the Intellectual Property Group, is based in the Los Angeles office. He has represented plaintiffs and defendants in numerous high-profile IP cases. He is experienced with litigation in dozens of U.S. district courts, the International Trade Commission (ITC), the Federal Circuit, the Patent Trial and Appeal Board, and Japanese courts. He received his J.D. from Harvard Law School, his M.S. in electrical engineering from the Georgia Institute of Technology and his B.S. from the University of Florida.
• Eric Pai, a member of the Intellectual Property Group, is based in the Palo Alto office. He represents clients in patent litigation involving a wide range of technologies, including pharmaceuticals, biotechnology, medical devices, smartphones, GPS systems, wireless telecommunications, software, and semiconductors. Mr. Pai has also represented technology and life sciences companies in complex commercial litigation and licensing disputes. He has examined witnesses and presented closing arguments at trial and successfully argued Markman and summary judgment hearings. Mr. Pai received his J.D. from Yale Law School and his B.A. from Stanford University.
• Karen Potter Ph.D., a member of the Patent Group, is based in the San Diego office. Dr. Potter provides strategic patent portfolio management for clients in the life sciences industry, including services related to patent preparation, prosecution, freedom of operation, and other forms of IP assessment and due diligence review. Dr. Potter has experience in a variety of biotechnology-related areas, including in the fields of cell-based and protein immunotherapies, other antibody and protein therapeutics, and diagnostic assays. Dr. Potter earned her Ph.D. in cellular and molecular biology from Duke University and was a postdoctoral fellow at The La Jolla Institute for Allergy and Immunology. Dr. Potter received her J.D. from California Western School of Law and her B.S. from the University of California, San Diego.
• Yuka Teraguchi, a member of the Litigation Department, is based in the Tokyo office. Ms. Teraguchi focuses her practice on intellectual property litigation and counseling, and she represents clients in complex technology matters in state and federal courts and before the U.S. International Trade Commission. The technology at issue in these matters has covered areas such as computer hardware and software, communications networks, consumer electronics, semiconductor devices, and medical devices. Before joining the firm, she clerked for the Honorable Randall R. Rader, Chief Judge at the U.S. Court of Appeals for the Federal Circuit. Ms. Teraguchi received her J.D. from The George Washington University Law School and her B.S. from Stanford University.
• Sarah Thomas, a member of the Litigation Department, is based in the Hong Kong office. Her practice focuses on international arbitration, internal investigations and commercial litigation throughout the Asia-Pacific region, and she has particular experience in matters relating to China, Hong Kong, India, Singapore, Malaysia and Japan. She regularly advises clients on complex disputes and investigations across a wide range of industries, including technology, engineering, manufacturing, healthcare/pharmaceuticals, automotive, insurance and telecoms. Ms. Thomas is qualified in New York, England & Wales and Hong Kong. Ms. Thomas received her LL.B. from the London School of Economics and her J.D. from Columbia Law School.
• Claudia Vetesi, a member of the Litigation Department, is based in the San Francisco office. Ms. Vetesi focuses her practice on the defense of consumer class actions and on complex commercial litigation, including unfair competition, false advertising, privacy issues, contract and licensing disputes, financial services litigation, and trade secrets misappropriation. She regularly counsels clients in the food, retail, financial, and technology industries. She also represents companies in false advertising disputes before the National Advertising Division of the Council of Better Business Bureaus. Ms. Vetesi is active in the firm’s pro bono efforts and has appeared in federal court numerous times on behalf of clients in various criminal matters. She is a member of the American Inns of Court and a recipient of the State Bar of California’s Wiley W. Manuel Award for public service. She received her J.D. from the University of California, Berkeley, School of Law and her B.A. from the University of California, Berkeley.